These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19048929)

  • 1. [Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with oral anticoagulant therapy].
    Hori Y; Kuromatsu I; Sugimura Y
    Hinyokika Kiyo; 2008 Oct; 54(10):651-6. PubMed ID: 19048929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoselective vaporization of the prostate using high power (80 W) KTP laser: one year follow up of the first 101 patients in Japan.
    Hori Y; Kuromatsu I; Sugimura Y
    Int J Urol; 2008 Dec; 15(12):1067-71. PubMed ID: 19054171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
    Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
    Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.
    Sandhu JS; Ng C; Vanderbrink BA; Egan C; Kaplan SA; Te AE
    Urology; 2004 Dec; 64(6):1155-9. PubMed ID: 15596189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients.
    Reich O; Bachmann A; Siebels M; Hofstetter A; Stief CG; Sulser T
    J Urol; 2005 Jan; 173(1):158-60. PubMed ID: 15592063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.
    Ruszat R; Wyler S; Forster T; Reich O; Stief CG; Gasser TC; Sulser T; Bachmann A
    Eur Urol; 2007 Apr; 51(4):1031-8; discussion 1038-41. PubMed ID: 16945475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of 80 W KTP laser vaporization of the large prostate.
    Tugcu V; Tasci AI; Sahin S; Ordekci Y; Karakas OF; Zorluoglu F
    Urol Int; 2007; 79(4):316-20. PubMed ID: 18025849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate.
    Cho MC; Kim HS; Lee CJ; Ku JH; Kim SW; Paick JS
    Urology; 2010 Jun; 75(6):1460-6. PubMed ID: 19963247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoselective vaporization of the prostate: the basel experience after 108 procedures.
    Bachmann A; Ruszat R; Wyler S; Reich O; Seifert HH; Müller A; Sulser T
    Eur Urol; 2005 Jun; 47(6):798-804. PubMed ID: 15925076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Seki N; Nomura H; Yamaguchi A; Naito S
    J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.
    Elzayat EA; Al-Mandil MS; Khalaf I; Elhilali MM
    J Urol; 2009 Jul; 182(1):133-8. PubMed ID: 19447438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
    Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
    Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
    Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
    Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
    Paick JS; Um JM; Kwak C; Kim SW; Ku JH
    Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients.
    Yuan J; Wang H; Wu G; Liu H; Zhang Y; Yang L
    Postgrad Med J; 2008 Jan; 84(987):46-9. PubMed ID: 18230751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.